Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelia Passia

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Revue Medicale Suisse|July 19, 2017
[Spinal injection : risks and side effects]Evangelia Passia, Stéphane Genevay
Revue Medicale Suisse|April 6, 2018
[Mastcell activation syndrome]Evangelia Passia, Peter Jandus
Clinical Reviews in Allergy & Immunology|February 9, 2020
Using Baseline and Peak Serum Tryptase Levels to Diagnose Anaphylaxis: a ReviewEvangelia Passia, Peter Jandus
Revue Medicale Suisse|March 15, 2023
[Can we prevent the occurrence of Rheumatoid Arthritis in 2023?]Evangelia Passia, Aline Schläpfer, Axel Finckh
Frontiers in Pharmacology|May 10, 2017
"Late" Withdrawal Syndrome after Carbamazepine <i>In Utero</i> Exposure in a CYP2C9 Slow Metabolizer NewbornEvangelia Passia, Nathalie Rock, Riccardo E Pfister, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Revue Medicale Suisse|July 19, 2017
[Spinal injection : risks and side effects]Evangelia Passia, Stéphane Genevay
Revue Medicale Suisse|April 6, 2018
[Mastcell activation syndrome]Evangelia Passia, Peter Jandus
Clinical Reviews in Allergy & Immunology|February 9, 2020
Using Baseline and Peak Serum Tryptase Levels to Diagnose Anaphylaxis: a ReviewEvangelia Passia, Peter Jandus
Revue Medicale Suisse|March 15, 2023
[Can we prevent the occurrence of Rheumatoid Arthritis in 2023?]Evangelia Passia, Aline Schläpfer, Axel Finckh
Frontiers in Pharmacology|May 10, 2017
"Late" Withdrawal Syndrome after Carbamazepine <i>In Utero</i> Exposure in a CYP2C9 Slow Metabolizer NewbornEvangelia Passia, Nathalie Rock, Riccardo E Pfister, et al.
Pageof 1